Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dingell Challenged To Document Reasons For Supplement Safety Doubts

This article was originally published in The Tan Sheet

Executive Summary

The president of Jarrow Formulas has formally challenged House Energy and Commerce Committee Chairman John Dingell, D-Mich., to back up claims that dietary supplements "are killing people," and says he does not expect Dingell will act on plans to conduct hearings on the Dietary Supplement Health and Education Act

You may also be interested in...



Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group

A dietary supplement trade group founded by Jarrow Rogovin plans to aggressively protect the industry’s interests, including filing lawsuits and Freedom of Information Act requests.

Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group

A dietary supplement trade group founded by Jarrow Rogovin plans to aggressively protect the industry’s interests, including filing lawsuits and Freedom of Information Act requests.

Jarrow Formulas Founder Forms “More Creative” Supplement Trade Group

A dietary supplement trade group founded by Jarrow Rogovin plans to aggressively protect the industry’s interests, including filing lawsuits and Freedom of Information Act requests.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100309

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel